141 related articles for article (PubMed ID: 36098515)
21. The correlation between proteoglycan 2 and neuropsychiatric systemic lupus erythematosus.
Qiao X; Lu L; Zhou K; Tan L; Liu X; Ni J; Hou Y; Liang J; Dou H
Clin Immunol; 2022 Jun; 239():109042. PubMed ID: 35568106
[TBL] [Abstract][Full Text] [Related]
22. TNF-α regulates microglial activation via the NF-κB signaling pathway in systemic lupus erythematosus with depression.
Kong X; Zhang Z; Fu T; Ji J; Yang J; Gu Z
Int J Biol Macromol; 2019 Mar; 125():892-900. PubMed ID: 30572037
[TBL] [Abstract][Full Text] [Related]
23. Neuronal NR4A1 deficiency drives complement-coordinated synaptic stripping by microglia in a mouse model of lupus.
Han X; Xu T; Ding C; Wang D; Yao G; Chen H; Fang Q; Hu G; Sun L
Signal Transduct Target Ther; 2022 Feb; 7(1):50. PubMed ID: 35177587
[TBL] [Abstract][Full Text] [Related]
24. Treatment with lysophosphatidic acid improves glomerulonephritis through the suppression of macrophage activation in a murine model of systemic lupus erythematosus.
Nagata W; Takayama E; Nakagawa K; Koizumi A; Ohsawa Y; Goto H; Yamashiro A; Ishinoda Y; Tanoue K; Kumagai H; Oshima N; Ishizuka T
Clin Exp Rheumatol; 2024 Mar; 42(3):658-665. PubMed ID: 38436267
[TBL] [Abstract][Full Text] [Related]
25. Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.
Chalmers SA; Wen J; Doerner J; Stock A; Cuda CM; Makinde HM; Perlman H; Bosanac T; Webb D; Nabozny G; Fine JS; Klein E; Ramanujam M; Putterman C
Arthritis Res Ther; 2018 Jan; 20(1):10. PubMed ID: 29370834
[TBL] [Abstract][Full Text] [Related]
26. Paeoniflorin inhibits activation of the IRAK1-NF-κB signaling pathway in peritoneal macrophages from lupus-prone MRL/lpr mice.
Ji L; Hou X; Liu W; Deng X; Jiang Z; Huang K; Li R
Microb Pathog; 2018 Nov; 124():223-229. PubMed ID: 30149133
[TBL] [Abstract][Full Text] [Related]
27. Choroid Plexus-Infiltrating T Cells as Drivers of Murine Neuropsychiatric Lupus.
Moore E; Huang MW; Reynolds CA; Macian F; Putterman C
Arthritis Rheumatol; 2022 Nov; 74(11):1796-1807. PubMed ID: 35637551
[TBL] [Abstract][Full Text] [Related]
28. Accumulation of Senescent Neural Cells in Murine Lupus With Depression-Like Behavior.
Saito Y; Miyajima M; Yamamoto S; Sato T; Miura N; Fujimiya M; Chikenji TS
Front Immunol; 2021; 12():692321. PubMed ID: 34804003
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
30. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
31. Regulatory effect of IL-38 on NF-κB pathway in systemic lupus erythematosus.
Zhang J; Tabush N; Wei C; Luo L
Immunobiology; 2023 Mar; 228(2):152322. PubMed ID: 36621308
[TBL] [Abstract][Full Text] [Related]
32. Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus.
Lu F; Lu H; Xie M; Li S; Zu Y; Zhou J; Yu J; Wang S; Ruan Y; Wen C; Xu Z
Inflammopharmacology; 2019 Jun; 27(3):511-520. PubMed ID: 30911862
[TBL] [Abstract][Full Text] [Related]
33. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C
J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
[TBL] [Abstract][Full Text] [Related]
34. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
Wen J; Doerner J; Weidenheim K; Xia Y; Stock A; Michaelson JS; Baruch K; Deczkowska A; Gulinello M; Schwartz M; Burkly LC; Putterman C
J Autoimmun; 2015 Jun; 60():40-50. PubMed ID: 25911200
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
Zhang X; Wang G; Bi Y; Jiang Z; Wang X
Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317
[TBL] [Abstract][Full Text] [Related]
36. Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice.
Zhou J; Lu F; Li S; Xie M; Lu H; Xie Z; Wu D; Wang S; Wen C; Xu ZH
Inflammopharmacology; 2020 Apr; 28(2):425-435. PubMed ID: 31786803
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
[TBL] [Abstract][Full Text] [Related]
38. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
Zhai JX; Zhang ZX; Feng YJ; Ding SS; Wang XH; Zou LW; Ye DQ
Mol Biol Rep; 2012 Jun; 39(6):6763-71. PubMed ID: 22318546
[TBL] [Abstract][Full Text] [Related]
39. The Association between the Decreased Expression Levels of FOXJ1 and the Activation of the NF-kB Pathway in Interstitial Lung Disease of MR L/Lpr Mice.
Gao Y; Ge X; Wang X; Gu Z
Iran J Immunol; 2021 Sep; 18(3):210-219. PubMed ID: 34596586
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation.
Wu Y; He S; Bai B; Zhang L; Xue L; Lin Z; Yang X; Zhu F; He P; Tang W; Zuo J
Cell Mol Immunol; 2016 May; 13(3):379-90. PubMed ID: 25942599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
